Hans Lennart Rudolf Wigzell, Director at Sarepta Therapeutics, Inc. (SRPT), sold 10,500 shares at $124.84 ($1.3M) on 2024-12-12, disclosed to the SEC on 2024-12-16.
Open-market sale of $1.3M SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SRPT | SELL | 2021-03-10 | $835K | — | Filing → |
| SRPT | SELL | 2020-08-11 | $3.2M | — | Filing → |
| SRPT | SELL | 2020-05-22 | $1.2M | — | Filing → |